Literature DB >> 1309913

Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.

D A Simpson1, R A Lamb.   

Abstract

The influenza virus hemagglutinin (HA) contains a cytoplasmic domain that consists of 10 to 11 amino acids, of which five residues have sequence identity for 10 of 13 HA subtypes. To investigate properties of these conserved residues, oligonucleotide-directed mutagenesis was performed, using an HA cDNA of influenza virus A/Udorn/72 (H3N2) to substitute the conserved cysteine residues with other residues, to delete the three C-terminal conserved residues, or to remove the entire cytoplasmic domain. The altered HAs were expressed in eukaryotic cells, and the rates of intracellular transport were examined. It was found that substitution of either conserved cysteine residue within the cytoplasmic domain did not affect the rate of intracellular transport, whereas deletion of residues within the C-terminal domain resulted in delayed cell surface expression. All the altered HAs were biologically active in hemadsorption and fusion assays. To investigate whether the wild-type HA and HAs with altered cytoplasmic tails could complement the influenza virus temperature-sensitive transport-defective HA mutant A/WSN/33 ts61S, the HA cDNAs were expressed by using a transient expression system and released virus was assayed by plaque analysis. The wild-type HA expression resulted in a release of approximately 10(3) PFU of virus per ml. Antibody neutralization of complemented virus indicated that the infectivity was due to incorporation of wild-type H3 HA into ts61S virions. Sucrose density gradient analysis of released virions showed that each of the HA cytoplasmic domain mutants was incorporated into virus particles. Virions containing HAs with substitution of the cysteine residues in the cytoplasmic domain were found to be infectious. However, no infectivity could be detected from virions containing HAs that had deletions in their cytoplasmic domains. Possible roles of the HA cytoplasmic domain in forming protein-protein interactions in virions and their involvement in the initiation of the infection process in cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309913      PMCID: PMC240779     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Site-directed mutations in Sindbis virus E2 glycoprotein's cytoplasmic domain and the 6K protein lead to similar defects in virus assembly and budding.

Authors:  K Gaedigk-Nitschko; M J Schlesinger
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Mutations in the cytoplasmic domain of the 275 kd mannose 6-phosphate receptor differentially alter lysosomal enzyme sorting and endocytosis.

Authors:  P Lobel; K Fujimoto; R D Ye; G Griffiths; S Kornfeld
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582

4.  Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor.

Authors:  R G Paterson; R A Lamb
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

Review 5.  Protein folding and intracellular transport: evaluation of conformational changes in nascent exocytotic proteins.

Authors:  M J Gething; K McCammon; J Sambrook
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

6.  The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity.

Authors:  L Chakrabarti; M Emerman; P Tiollais; P Sonigo
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Influenza virus ts61S hemagglutinin is significantly defective in polypeptide folding and intracellular transport at the permissive temperature.

Authors:  D A Simpson; R A Lamb
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits.

Authors:  J Lazarovits; M Roth
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

10.  Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein.

Authors:  R W Doms; A Ruusala; C Machamer; J Helenius; A Helenius; J K Rose
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

View more
  34 in total

1.  Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.

Authors:  C Kozerski; E Ponimaskin; B Schroth-Diez; M F Schmidt; A Herrmann
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin.

Authors:  H Y Naim; B Amarneh; N T Ktistakis; M G Roth
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin.

Authors:  M Ohuchi; C Fischer; R Ohuchi; A Herwig; H D Klenk
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity.

Authors:  H Jin; K Subbarao; S Bagai; G P Leser; B R Murphy; R A Lamb
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.

Authors:  S Bagai; R A Lamb
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.

Authors:  J W Dubay; S J Roberts; B H Hahn; E Hunter
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport.

Authors:  K Takeuchi; R A Lamb
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Influenza A virus hemagglutinin and neuraminidase mutually accelerate their apical targeting through clustering of lipid rafts.

Authors:  Takashi Ohkura; Fumitaka Momose; Reiko Ichikawa; Kaoru Takeuchi; Yuko Morikawa
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions.

Authors:  K Inabe; M Nishizawa; S Tajima; K Ikuta; Y Aida
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.